University of Minnesota. Driven to Discover.
Meanwhile, the CDC published a clinical and epidemiological snapshot of US cases, revealing that 42% didn't report prodrome symptoms.
New studies continue to shed new light on the long-term impacts of COVID, including the development of cardiovasular and kidney complications in kids.
With COVID activity still high in many counties, Paxlovid prescribing is rising as another study shed light on rebound prevalence.
The announcement paves the way for increased funds for tests, vaccines, and treatments.
Only one-fifth say they plan to have their preschooler vaccinated within 3 months.
EMS workers are scrambling to adapt treatment protocols and conduct training on their use.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2022 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.